Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders

US Patent 10314893 · Granted Jun 11, 2019

Assignee

Inventors

View full patent text on Google Patents →